CGM improves glycemic control in critically ill patients in ICU on intravenous insulin
USA: A new study published in the Journal of Diabetes Science and Technology shows that continuous glucose monitoring improved glycemic control in critically ill COVID-19 patients under IV insulin.
Although it is presently not licensed for inpatients, continuous glucose monitoring (CGM) is used to make insulin dosing decisions in the ambulatory setting. In patients with coronavirus disease 2019 (COVID-19), CGM has the potential to reduce patient-provider interaction, potentially lowering the spread of the virus within the hospital. There is, however, a lack of information about the precision and effectiveness of CGM in titrating insulin dosages in inpatients. In order to relate glycemic outcomes and CGM accuracy to POC measurements, Schafer Boeder and colleagues report on data gathered from 24 people.
CGM (Dexcom G6) was employed in this trial under an emergency usage strategy in conjunction with common point-of-care (POC) glucose readings in patients who were severely unwell with COVID-19 problems and required intravenous (IV) insulin. Retrospective evaluation of glycemic control during IV insulin treatment compared periods with and without concomitant CGM usage. Clarke Error Grid analysis was done to compare CGM glucose levels with POC data, and accuracy metrics were calculated.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.